Galderma is proud to share new data from two investigator-initiated studies addressing aesthetic changes associated with weight loss medications and menopause.  Dr. Andreas Nikolis examined treatment sequencing with Restylane Skinboosters and Sculptra in women during menopause, with interim results showing meaningful improvements in skin hydration, barrier function, and overall skin quality. Earlier hydration gains were shown when treatment begins with Restylane Skinboosters, with 88% of partici ...

Galderma

At Galderma, we’ve identified two forces rapidly reshaping patients’ aesthetic needs: medication‑driven weight loss and menopause.  I’m pleased to welcome interim results from two investigator‑initiated studies, supported by Galderma, providing critical insights into how to address these needs. For women in menopause, a study designed and executed by Dr. Andreas Nikolis shows how Restylane® Skinboosters™ and Sculptra® work synergistically to improve skin barrier function and hydration across the ...

Galderma

Aesthetic needs are evolving rapidly, driven by growing phenomena such as medication-driven weight loss and the long-overlooked skin changes that accompany menopause. New interim results from two investigator-initiated studies help bring greater scientific clarity to these two aesthetic needs. The studies underscore the value of regenerative treatment approaches, and provide insight into how treatment sequencing of Restylane® Skinboosters™ and Sculptra® may be optimized for patients experiencing ...

Galderma